P53 and anti‐p53 autoantibody complex versus anti‐p53 antibody as a biomarker for gastrointestinal cancer

Documenti analoghi

• p95HER2 expression in HER2‐positive breast cancer with primary resistance
  di: Chih Wan Goh, et al.
  Pubblicazione: (2024)
• EGFR and JAK2 were significant master gene biomarkers in invasive and noninvasive pituitary adenoma
  di: Afsaneh Ghasemi, et al.
  Pubblicazione: (2025)
• Factors associated with the onset and survival of subsequent primary breast cancer in female non‐metastatic breast cancer survivors
  di: Shunshun Liang, et al.
  Pubblicazione: (2024)
• A latent profile analysis of self‐advocacy and their relationship to differences in unmet cancer needs in patients with breast cancer chemotherapy
  di: Zhimin Liu, et al.
  Pubblicazione: (2025)
• LncRNA C7orf13 facilitates cell proliferation and metastasis in nasopharyngeal carcinoma via targeting miR‐449c/miR‐28‐5p‐FMNL2 axis
  di: Peng Xie, et al.
  Pubblicazione: (2024)